Peacock has a little bit of everything. The streaming home of Saturday Night Live and the Law & Order franchise keeps the NBC vibes going on its platform with a collection of originals that reflect a ...

From terrifying paranormal tales to nail-biting thrillers and everything in between, these are the best Stephen King books in every genre that you'll devour Our editors and experts handpick every ...

Rainbow, an independent Italian entertainment company helmed by Iginio Straffi, has acquired the IP rights to Geronimo Stilton, one of the most successful children’s publishing brands of the past two ...

Last night's "WWE NXT" saw Thea Hail win her first-ever championship in wrestling, as she pinned Blake Monroe to become the new WWE NXT Women's North American Champion. The match had an unusual finish ...

Rainbow has acquired the intellectual property rights to Geronimo Stilton, marking a significant new chapter for the globally recognized children’s literary franchise. The Italian entertainment group, ...

A Cambridge student has set up a free speech society after being targeted for reading 'Terf' gender-critical books. Thea Sewell, 20, is running a female-only group to ‘encourage women to speak freely’ ...

IMDb.com, Inc. takes no responsibility for the content or accuracy of the above news articles, Tweets, or blog posts. This content is published for the entertainment of our users only. The news ...

One of the easiest ways to get kids hooked on reading is to get them into a great book series. All it takes is a captivating Book 1, and they're off and running. Fantasy, mystery, science fiction, ...

Teen readers can't get enough of trilogies and multipart series that keep them on the edge of their seat, waiting for the next installment. Whether it's a dystopian series or a science fiction, ...

BURLINGAME, Calif., Dec. 03, 2025 (GLOBE NEWSWIRE) -- Iolyx Therapeutics, a clinical-stage biotechnology company focused on the development of therapeutics at the intersection of ocular inflammation ...

Laboratoires Théa has penned a deal potentially worth up to $280 million to get its hands on Iolyx Therapeutics’ phase 3-ready eye disease drug. The asset in question is ILYX-002, a topical ...